A Bioinspired Platform for Effective Delivery of Protein Therapeutics to the Central Nervous System

被引:100
|
作者
Wu, Di [1 ]
Qin, Meng [2 ]
Xu, Duo [1 ]
Wang, Lan [3 ,9 ]
Liu, Chaoyong [2 ]
Ren, Jie [1 ]
Zhou, George [1 ]
Chen, Chen [1 ]
Yang, Fengmei [4 ,5 ]
Li, Yanyan [4 ,5 ]
Zhao, Yuan [4 ,5 ]
Huang, Ruyi [6 ]
Pourtaheri, Sina [7 ]
Kang, Chunsheng [8 ]
Kamata, Masakazu [9 ,10 ]
Chen, Irvin S. Y. [3 ,9 ]
He, Zhanlong [4 ,5 ]
Wen, Jing [3 ,9 ]
Chen, Wei [11 ]
Lu, Yunfeng [1 ]
机构
[1] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA
[2] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Coll Life Sci & Technol, Beijing 100029, Peoples R China
[3] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[4] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China
[5] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China
[6] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA
[7] Univ Calif San Diego, Dept Orthoped Surg, San Diego, CA 92093 USA
[8] Tianjin Med Univ, Gen Hosp, MOE Key Lab Postneuroinjury Neurorepair & Regener, Tianjin Neurol Inst, Tianjin 300052, Peoples R China
[9] UCLA, AIDS Inst, Los Angeles, CA 90095 USA
[10] UCLA, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
[11] Beijing Inst Biotechnol, Beijing 100071, Peoples R China
关键词
blood-brain barrier penetration; central nervous system delivery; nanocapsules; nanomedicine; BLOOD-BRAIN-BARRIER; NICOTINIC ACETYLCHOLINE-RECEPTOR; HIGH-AFFINITY CHOLINE; FACTOR GENE-THERAPY; GROWTH-FACTOR; RAT-BRAIN; NANOPARTICLES; DRUG; TRANSPORTER; DISRUPTION;
D O I
10.1002/adma.201807557
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Central nervous system (CNS) diseases are the leading cause of morbidity and mortality; their treatment, however, remains constrained by the blood-brain barrier (BBB) that impedes the access of most therapeutics to the brain. A CNS delivery platform for protein therapeutics, which is achieved by encapsulating the proteins within nanocapsules that contain choline and acetylcholine analogues, is reported herein. Mediated by nicotinic acetylcholine receptors and choline transporters, such nanocapsules can effectively penetrate the BBB and deliver the therapeutics to the CNS, as demonstrated in mice and non-human primates. This universal platform, in general, enables the delivery of any protein therapeutics of interest to the brain, opening a new avenue for the treatment of CNS diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics
    Soderquist, Ryan G.
    Mahoney, Melissa J.
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (03) : 285 - 293
  • [22] Strategies for Enhanced Drug Delivery to the Central Nervous System
    Dwibhashyam, V. S. N. M.
    Nagappa, A. N.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (02) : 145 - 153
  • [23] Polymeric nanoparticles for drug delivery to the central nervous system
    Patel, Toral
    Zhou, Jiangbing
    Piepmeier, Joseph M.
    Saltzman, W. Mark
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 701 - 705
  • [24] Nanobiotechnology - Based drug delivery to the central nervous system
    Jain, K. K.
    NEURODEGENERATIVE DISEASES, 2007, 4 (04) : 287 - 291
  • [25] Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy
    Han, Lei
    Liu, Chaoyong
    Qi, Hongzhao
    Zhou, Junhu
    Wen, Jing
    Wu, Di
    Xu, Duo
    Qin, Meng
    Ren, Jie
    Wang, Qixue
    Long, Lixia
    Liu, Yang
    Chen, Irvin
    Yuan, Xubo
    Lu, Yunfeng
    Kang, Chunsheng
    ADVANCED MATERIALS, 2019, 31 (19)
  • [26] Monoolein-based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment
    Donida, Bruna
    Tauffner, Barbara
    Raabe, Marco
    Immich, Maira F.
    de Farias, Marcelo A.
    Coutinho, Diego de Sa
    Machado, Andryele Zaffari
    Kessler, Rejane Gus
    Portugal, Rodrigo V.
    Bernardi, Andressa
    Frozza, Rudimar
    Moura, Dinara J.
    Poletto, Fernanda
    Vargas, Carmen Regla
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 133 : 96 - 103
  • [27] Nucleic acid-based therapeutics for the treatment of central nervous system disorders
    Mccartan, Robyn
    Khorkova, Olga
    Volmar, Claude-Henry
    Wahlestedt, Claes
    FRONTIERS IN GENETICS, 2023, 14
  • [28] Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System
    McConnell, Erin M.
    Holahan, Matthew R.
    DeRosa, Maria C.
    NUCLEIC ACID THERAPEUTICS, 2014, 24 (06) : 388 - 404
  • [29] Nanomaterials for delivery of nucleic acid to the central nervous system (CNS)
    Wang, Danyang
    Wu, Lin-Ping
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 70 : 1039 - 1046
  • [30] Frizzled fissure to improve central nervous system drug delivery?
    Drewes, Lester R.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (08): : 1257 - 1257